President of the IMS Professor Susan Davis responds to The Lancet paper, a meta analysis on hormonal factors in breast cancer and menopause hormone therapy (MHT).
President of the IMS Professor Susan Davis responds to The Lancet paper, a meta analysis on hormonal factors in breast cancer and menopause hormone therapy (MHT).